Fiocruz Brasil is delaying registration of the AstraZeneca vaccine pending fast track approval | Instant News

RIO DE JANEIRO, 14 Jan (Reuters) – Brazil’s biomedical center Fiocruz has re-submitted its request to register the COVID-19 vaccine developed by AstraZeneca PLC until next week, said its vice president Marco Krieger.

Fiocruz originally planned to make a request on Friday, but Krieger said it was best to wait for an emergency authorization request that Anvisa’s health regulator hopes will provide on Sunday.

Reporting by Pedro Fonseca Editing by Chris Reese


image source

to request modification Contact us at Here or [email protected]